Arguments favouring the pharmacotherapy of Bells' palsy;Vóór medicamenteuze behandeling van Bell-paralyse

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 26, 2005, Pages 1454-

  De Ru, J A ^a,b   Van Benthem, P P G ^a   Hordijk, G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GELRE HOSPITALS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; PREDNISONE; VALACICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; BELL PALSY; CORTICOSTEROID THERAPY; FACIAL NERVE PARALYSIS; HERPES VIRUS; HUMAN; VIRUS INHIBITION; VIRUS REACTIVATION;

ACYCLOVIR; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BELL PALSY; HERPESVIRIDAE INFECTIONS; HUMANS; PREDNISONE; TREATMENT OUTCOME; VALINE; VIRUS ACTIVATION;

EID: 21244440658     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Devriese PP. De verlamming van Bell. Nederlands Tijdschrift voor Keel-Neus-Oorheelkunde 2003;2:67-71.
2. Grogan PM, Gronseth GS. Practice parameter: steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:830-6.
3. Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ 2004;329:553-7.
4. Axelsson S, Lindberg S, Stjernquist-Desatnik A. Outcome of treatment with valacyclovir and prednisone in patients with Bell's palsy. Ann Otol Rhinol Laryngol 2o03;112:197-201.